MRIDIAN CLINICAL COMPANY CONTACT LOGIN GLOBAL MRIdian SMART Stereotactic MRI-Guided Adaptive Radiotherapy. A New Paradigm in Radiation Oncology Over the past 30 years, conventional IGRT has introduced many life saving developments, yet poor soft tissue contrast, the use of surrogates to identify anatomy, and having no real-time imaging during beam-on have often constrained clinical potential. Combining the latest innovations in precision radiation delivery with groundbreaking MR image guidance and on-table adaptive therapy, it’s time for the next big advance in radiation oncology. The future of radiation therapy is here. First pioneered by ViewRay in 2012, MRI-Guided SMART™ represents a new paradigm in the treatment of cancer, providing clinicians with the ability to improve targeting precision and thus deliver higher, and potentially more effective, radiation doses. WATCH VIDEO Contact Us Today To Learn More CONTACT Home Old Safety Privacy Legal MR-Guided SMART Discover MRIdian MRIdian Locator Medical Affairs Bibliography About ViewRay Newsroom Investors Partner Program Careers Contact ViewRay Headquarters 2 Thermo Fisher Way Oakwood Village, OH 44146 +1 440.703.3210 Phone +1 800.417.3459 Fax West Coast Office 815 E Middlefield Rd Mountain View, CA 94043 +1 650.252.0920 Phone © 2021 VIEWRAY TECHNOLOGIES, INC. (“VIEWRAY”). ALL RIGHTS RESERVED. INTENDED FOR HEALTHCARE PROFESSIONALS ONLY. This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of our products and services, assist with our promotional and marketing efforts, and provide content from third parties. Cookie Policy ACCEPT